CFO Samuelson Doug Purchases $3,750 Worth of Shares
The Chief Financial Officer of Kairos Pharma, Doug Samuelson, recently made a noteworthy investment in the company’s stock. On November 22, 2024, Samuelson purchased 2,500 units of common stock at $1.50 per unit, totaling $3,750. This transaction resulted in a 4% increase in his direct ownership of Kairos Pharma, bringing his total to 60,796 units.
This information comes from a Form 4 filing submitted to the United States Securities and Exchange Commission (SEC). Form 4 is required to be filed by insiders of publicly traded companies to report any changes in their ownership of the company’s stock.
As the Chief Financial Officer of Kairos Pharma, this purchase by Samuelson highlights his confidence in the company’s performance and future prospects. It’s always interesting to see insiders investing in the companies they work for, as it can signal a positive outlook and alignment between management and shareholders.
For investors and those following Kairos Pharma, Samuelson’s recent purchase may serve as a vote of confidence in the company’s direction. Insider transactions like this can be a valuable piece of information for those analyzing investment opportunities in a particular company.
As always, it’s essential to conduct thorough research and consider various factors before making any investment decisions. Watching the actions of insiders, such as CFO Doug Samuelson, can be one part of a comprehensive investment strategy.
